Clinical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection

Effective and safe contraceptive methods not only prevent unplanned pregnancies and their termination, but also make it possible to fully restore the mother's body after surgery to carry out the necessary pre-pregnancy preparation. The goal of the study was to evaluate the clinical outcome of postplacental administration of Cu T 380 A in women during a caesarean section. The study was conducted at Samarkand Maternity Hospital No. 2 to assess the clinical outcome of postplacental administration of Cu T 380 A in women during caesarean section. The present study showed that there were no serious complications and only minor side effects such as pain, fever, bleeding and irregular bleeding, which were observed only in some women during the hospital stay and the control visit in the first 6 months. The determination of vaginal BMW tendrils was made possible in 72.12% of women during the control visit after 6 weeks. The visibility of the tendrils increased over time and after 6 months they were seen in 90.81% of cases. Exposure frequency was 2 cases (4%) and another 2 women (4%) required removal of the PMTCT for various reasons, resulting in a 92.3% retention rate six months after contraception. No cases of pregnancy were registered. Post-placental introduction of BIC Cu T 380 A during a C-section is a practical, convenient, safe, effective and acceptable contraceptive method.